Literature DB >> 15178191

Analysis of compartmental models of ligand-induced endocytosis.

Abraham R Tzafriri1, David Wu, Elazer R Edelman.   

Abstract

Kinetic models have played a pivotal role in the study of ligand-induced endocytosis. However, an analysis that suggests a systematic way to validate such models is lacking. The current work analyses the base model of ligand-induced endocytosis for three widely used experimental protocols. In protocol I cells initially devoid of ligand are incubated in ligand solution, whereas protocols II and III are desorption experiments in which an initial pool of surface or internalized ligand-receptor complexes, respectively, are released into an elution medium that is initially devoid of ligand. A short-time analysis of protocol I using successive substitutions yielded a corrected pre-factor for the In/Sur plot introduced by Wiley and Cunningham (Cell 25 (1981) 433). In contrast, neglecting the variation in receptor numbers yielded an approximation of protocol I that is valid for long times (e.g. tens of minutes). Similarly, the low cell-concentration limits of protocols II and III are derived by neglecting the concentration of free ligand. The simplicity of these approximations provides a simple and reliable method for estimating the parameters governing ligand kinetics, while their definitive nature implies that they can be used to verify the validity of the base model. This analysis also provides insight on the fast endocytosis and recycling limit of protocol III. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178191     DOI: 10.1016/j.jtbi.2004.03.009

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  7 in total

1.  Endosomal receptor kinetics determine the stability of intracellular growth factor signalling complexes.

Authors:  A Rami Tzafriri; Elazer R Edelman
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

2.  Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance.

Authors:  Jessica N Hodge; Sharat Srinivasula; Zonghui Hu; Sarah W Read; Brian O Porter; Insook Kim; Joann M Mican; Chang Paik; Paula Degrange; Michele Di Mascio; Irini Sereti
Journal:  Blood       Date:  2011-07-21       Impact factor: 22.113

3.  The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.

Authors:  Claire E Bamberg; Charles R Mackay; Hyun Lee; David Zahra; Jenny Jackson; Yun Si Lim; Peter L Whitfeld; Stewart Craig; Erin Corsini; Bao Lu; Craig Gerard; Norma P Gerard
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

4.  Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization.

Authors:  Eva Jager; Vincent H J van der Velden; Jeroen G te Marvelde; Roland B Walter; Zvia Agur; Vladimir Vainstein
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

5.  Experimental Evaluation of the Transport Mechanisms of PoIFN-α in Caco-2 Cells.

Authors:  Xin Liu; Sidi Zheng; Yue Qin; Wenya Ding; Yabin Tu; Xingru Chen; Yunzhou Wu; Li Yanhua; Xuehui Cai
Journal:  Front Pharmacol       Date:  2017-11-07       Impact factor: 5.810

Review 6.  The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems.

Authors:  Nahor Haddish-Berhane; Jenna L Rickus; Kamyar Haghighi
Journal:  Int J Nanomedicine       Date:  2007

7.  One-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine.

Authors:  Jing-Wen Luo; Zhi-Rong Zhang; Tao Gong; Yao Fu
Journal:  Int J Nanomedicine       Date:  2016-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.